Evidence map›Paper›PMID 27044259›Full record

Observational studyArchives of disease in childhood2016

Dilemma of managing asymptomatic children referred with 'culture-confirmed' drug-resistant tuberculosis.

Marian Loveday, Babu Sunkari, Ben J Marais, Iqbal Master, James C M Brust

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Archives of disease in childhood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics.European respiratory review : an official journal of the European Respiratory Society · 2024
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Tuberculosis susceptibility and protection in children.The Lancet. Infectious diseases · 2019
    Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Marian LovedayHealth Systems Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Babu SunkariDrug-resistant TB Unit, KwaZulu-Natal Department of Health, King Dinuzulu Hospital, Durban, South Africa.
Ben J MaraisClinical School, Children's Hospital at Westmead, University of Sydney, Sydney, Australia.
Iqbal MasterDrug-resistant TB Unit, KwaZulu-Natal Department of Health, King Dinuzulu Hospital, Durban, South Africa.
James C M BrustDepartment of Medicine, Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, New York, USA.
Albert Einstein College of Medicine · USSouth African Medical Research Council · ZAUniversity of Sydney · AU

Funding

Integrated, Home-based Treatment for MDR TB and HIV in Rural South AfricaK23AI083088 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BRUST, JAMES C M · 2010 to 2014
$665k
NIAID NIH HHS K23 AI083088
6 · The paper itself

Abstract

backgroundThe diagnosis of drug-resistant tuberculosis (DR-TB) in children is challenging and treatment is associated with many adverse effects.

objectiveWe aimed to assess if careful observation, without initiation of second-line treatment, is safe in asymptomatic children referred with 'culture-confirmed' DR-TB.

settingKwaZulu-Natal, South Africa-an area with high burdens of HIV, TB and DR-TB. DESIGN, INTERVENTION AND

main outcome measuresWe performed an outcome review of children with 'culture-confirmed' DR-TB who were not initiated on second-line TB treatment, as they were asymptomatic with normal chest radiographs on examination at our specialist referral hospital. Children were followed up every other month for the first year, with a final outcome assessment at the end of the study.

resultsIn total, 43 asymptomatic children with normal chest radiographs were reviewed. The median length of follow-up until final evaluation was 549 days (IQR 259-722 days); most (34; 83%) children were HIV uninfected. Resistance patterns included 9 (21%) monoresistant and 34 (79%) multidrug-resistant (MDR) strains. Fifteen children (35%) had been treated with first-line TB treatment, prior to presentation at our referral hospital. At the final evaluation, 34 (80%) children were well, 7 (16%) were lost to follow-up, 1 (2%) received MDR-TB treatment and 1 (2%) died of unknown causes. The child who received MDR-TB treatment developed new symptoms at the 12-month review and responded well to second-line treatment.

conclusionsBacteriological evaluation should not be performed in the absence of any clinical indication. If drug-resistant Mycobacterium tuberculosis is detected in an asymptomatic child with a normal chest radiograph, close observation may be an appropriate strategy, especially in settings where potential laboratory error and poor record keeping are constant challenges.

Indexed as

Antitubercular AgentsChildChild, PreschoolDrug Resistance, BacterialFemaleHumansInfantMaleMycobacterium tuberculosisRadiography, ThoracicReferral and ConsultationTreatment OutcomeTuberculosisTuberculosis, Multidrug-ResistantWatchful WaitingAntitubercular AgentsAsymptomaticchildrenDR-TBHIVmanagement

Identifiers

PMID27044259
PMCPMC4996348
OpenAlexW2341865130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.